Related Experiment Video
Updated: May 27, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Interventional treatment of venous thromboembolism: a review
Davide Imberti1, Walter Ageno, Roberto Manfredini
1Department of Internal Medicine, Piacenza Hospital, Italy. d.imberti@ausl.pc.it
Insights
Venous thromboembolism (VTE) management involves anticoagulation, but interventional approaches like vena cava filters, catheter-guided thrombolysis, and thrombosuction are crucial for select patients. This review details their efficacy, safety, and clinical indications.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Hematology
Background:
- Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cause of morbidity and mortality.
- Full dose anticoagulation is the established standard therapy for acute and long-term VTE management.
- Current guidelines recommend anticoagulants (UFH, LMWH, fondaparinux, VKA) or thrombolysis for confirmed VTE.
Purpose of the Study:
- To review the current literature on interventional VTE treatments.
- To discuss the efficacy and safety of vena cava filters, catheter-guided thrombolysis, and thrombosuction.
- To outline appropriate indications for these interventional approaches in clinical practice.
Main Methods:
- Literature review of interventional VTE treatment strategies.
- Analysis of evidence regarding the efficacy and safety of vena cava filters, catheter-guided thrombolysis, and thrombosuction.
- Discussion of clinical indications for interventional VTE therapies.
Main Results:
- Interventional approaches are reserved for specific patient populations.
- Vena cava filters prevent PE in patients with contraindications or complications from anticoagulation.
- Catheter-guided thrombolysis and thrombosuction are options for selected VTE cases.
Conclusions:
- Interventional therapies play a role in VTE management for carefully selected patients.
- Understanding the efficacy, safety, and indications is vital for appropriate clinical application.
- Further research may refine the role of interventional strategies in VTE treatment.
Abstract:
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease after coronary artery disease and cerebrovascular disease and is responsible for significant morbidity and mortality in the general population. Full dose anticoagulation is the standard therapy for VTE, both for the acute and the long-term phase. The latest guidelines of the American College of Chest Physicians recommend treatment with a full-dose of unfractioned heparin (UFH), low-molecular-weight-heparin (LMWH), fondaparinux, vitamin K antagonist (VKA) or thrombolysis for most patients with objectively confirmed VTE. Catheter-guided thrombolysis and trombosuction are interventional approaches that should be used only in selected populations; interruption of the inferior vena cava (IVC) with a filter can be performed to prevent life-threatening PE in patients with VTE and contraindications to anticoagulant treatment, bleeding complications during antithrombotic treatment, or VTE recurrences despite optimal anticoagulation. In this review we summarize the currently available literature regarding interventional approaches for VTE treatment (vena cava filters, catheter-guided thrombolysis, thrombosuction) and we discuss current evidences on their efficacy and safety. Moreover, the appropriate indications for their use in daily clinical practice are reviewed.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
